Literature Recap: Commentaries and editorials
Posted in Papers / Commentaries and editorials / October 16-31, 2026
Editors’ Note: Calcitonin Gene-Related Peptide Inhibitors and Cardiovascular Risk in People With Migraine
Posted on October 28, 2026
Posted in Papers / Commentaries and editorials / October 1-15, 2026
Fremanezumab for episodic migraine in children and adolescents: the evolving landscape of CGRP-targeted therapies
Posted on October 13, 2026
Posted in Papers / Commentaries and editorials / October 1-15, 2026
Science Is a Lot of Fun: How Professor Jes Olesen Made Discoveries in Migraine
Posted on October 13, 2026
Posted in Papers / Commentaries and editorials / October 1-15, 2026
Taking the LEAD in headache advocacy: Focus on migraine at school
Posted on October 8, 2026
Posted in Papers / Commentaries and editorials / October 1-15, 2026
Multimodal convergence is needed before inferring neuroaxonal injury in migraine
Posted on October 7, 2026
Posted in Papers / Commentaries and editorials / October 1-15, 2026
Guanfacine as a potential preventive therapy for chronic migraine: a mechanistic hypothesis
Posted on October 2, 2026
Posted in Papers / Commentaries and editorials / September 16-30, 2026
A new telos for migraine prevention: From potentiality to actuality through the IHS higher standards
Posted on September 16, 2026
Posted in Papers / Commentaries and editorials / September 16-30, 2026
A Migraine-Associated Na/K-ATPase Mutation Disrupts Hepatic Glucose Uptake and Peripheral Metabolism in Mice
Posted on September 16, 2026